Core Viewpoint - The stock of Crystal Tech Holdings (02228.HK), known as the "first AI pharmaceutical stock" in Hong Kong, experienced significant volatility on September 1, with a closing price of HKD 9.99 per share, down 3.1% for the day, despite an earlier increase of over 8% [1] Group 1: Stock Performance - Crystal Tech Holdings opened higher on September 1, reaching a peak increase of over 8% during the trading session [1] - The stock price closed at HKD 9.99 per share, reflecting a daily decline of 3.1% [1] Group 2: Company Response - In response to the stock's late-session decline, the company stated that it had not heard of any changes to its fundamentals and that everything was normal [1] Group 3: Share Placement and Fundraising - On August 29, Crystal Tech Holdings announced a share placement agreement to issue up to approximately 286 million shares at a price of HKD 9.28 per share, aiming to raise about HKD 2.63 billion [1] - The company has engaged in multiple share placements this year, including one on January 19 at HKD 4.28 per share, raising approximately HKD 1.13 billion, and another on February 19 at HKD 6.10 per share, raising about HKD 2.08 billion [1] Group 4: Financial Performance - For the first half of the fiscal year, Crystal Tech Holdings reported revenue of RMB 517 million, representing a year-on-year increase of 403.8% [2] - The company achieved an adjusted net profit of RMB 142 million for the first half of the fiscal year, marking its first semi-annual profit [2]
“AI制药第一股”晶泰控股回应尾盘股价“跳水”：未听说基本面有变化